Significant disruptions were observed in HIV-specific services, particularly for in-clinic and community-based HIV testing, according to the ECDC report "The impact of the COVID-19 pandemic on the HIV response in Europe and Central Asia."
At the request of the Slovenian National Institute of Public Health (NIJZ), ECDC designed and facilitated an After-Action review (AAR), focusing on the response to the COVID-19 pandemic.
The European Centre for Disease Prevention and Control (ECDC) is releasing its 2022 annual epidemiological report on Haemophilus influenzae disease in the European Union/European Economic Area (EU/EEA).
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 29 June−5 July 2024 and includes updates on SARS-CoV-2 variant classification, swine influenza, an overview of respiratory virus epidemiology in the EU/EEA, parvovirus infection, avian influenza, West Nile virus infections, mass gatherings and botulism.
ECDC regularly assesses new evidence on variants detected through epidemic intelligence, rules-based genomic variant screening or other scientific sources.
This report provides a record of the impact noted by countries on HIV services and monitoring capacity which can be used retrospectively to better understand the effects of the COVID-19 pandemic on the HIV situation in the European Region.
Overview of all the data available on the COVID-19 pandemic, including the The European Respiratory Virus Surveillance Summary (ERVISS) and variants of concern.
Nearly 7,000 excess deaths from tuberculosis occurred in the WHO European Region in the three years of the pandemic from 2020 - 2022, compared to what experts had expected based on pre-2020 estimates.